for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Laboratory Corp. of America Holdings

LH

Latest Trade

270.87USD

Change

-1.15(-0.42%)

Volume

710,369

Today's Range

270.44

 - 

278.54

52 Week Range

212.85

 - 

317.17

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
272.02
Open
274.14
Volume
710,369
3M AVG Volume
15.62
Today's High
278.54
Today's Low
270.44
52 Week High
317.17
52 Week Low
212.85
Shares Out (MIL)
95.70
Market Cap (MIL)
26,009.35
Forward P/E
9.92
Dividend (Yield %)
--

Next Event

Q4 2021 Laboratory Corporation of America Holdings Earnings Release

Latest Developments

More

Labcorp Announces Initiatives To Enhance Shareholder Value

Labcorp Says Averaged 114,000 Tests Per Day In Sept With Vols Declining Week Over Week Since That Time: Conf Call

Laboratory Corporation of America Holdings Announces 2021 Third Quarter Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Laboratory Corp. of America Holdings

Laboratory Corporation of America Holdings is a life sciences company that provides clinical laboratory and end-to-end drug development services. The Company’s business segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). Through its Dx and DD segments, the Company provides diagnostic, drug development and technology enabled solutions. The Company also supports clinical trial activity in approximately 100 countries through its industry central laboratory, preclinical, and clinical development businesses. Dx segment operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. DD segment, which operates on a global scale. The Company serves a range of customers, including doctors, hospitals, pharmaceutical companies, researchers, governmental agencies, physicians and other healthcare providers. It also helps in delivering non-clinical testing services.

Industry

Healthcare Facilities

Contact Info

358 S MAIN ST

BURLINGTON, NC

27215-5837

United States

+1.336.2291127

https://www.labcorp.com

Executive Leadership

Adam H. Schechter

President, Chief Executive Officer, Director

Glenn Andrew Eisenberg

Chief Financial Officer, Executive Vice President

Judith C. Seltz

Chief Human Resource Officer, Executive Vice President

Lance V. Berberian

Executive Vice President, Chief Technology Officer, Chief Information Officer

Amy B. Summy

Executive Vice President, Chief Marketing Officer

Key Stats

1.67 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

11.3K

2019

11.6K

2020

14.0K

2021(E)

16.0K
EPS (USD)

2018

11.020

2019

11.320

2020

23.940

2021(E)

27.567
Price To Earnings (TTM)
9.65
Price To Sales (TTM)
1.57
Price To Book (MRQ)
2.47
Price To Cash Flow (TTM)
7.42
Total Debt To Equity (MRQ)
52.41
LT Debt To Equity (MRQ)
52.29
Return on Investment (TTM)
16.42
Return on Equity (TTM)
13.96

Latest News

Latest News

Labcorp raises annual profit forecast as demand for clinical trials rebound

Laboratory Corp of America Holdings raised its full-year profit forecast on Thursday, following strong demand at its unit that performs clinical trials for drugmakers that also helped the company post a better-than-expected quarterly profit.

Labcorp profit drops 16.5% on slowing COVID-19 tests sales

Clinical laboratory operator Laboratory Corp of America Holdings on Thursday reported a 16.5% fall in quarterly profit due to slowing COVID-19 testing and higher personnel costs.

UPDATE 1-COVID-19 test maker Labcorp raises minimum hourly wage to $15

Laboratory Corp of America Holdings said it has increased the minimum hourly wage for U.S.-based employees to $15 from $10.95, joining several other companies in implementing new measures to retain staff amid a nationwide labor shortage.

COVID-19 test maker Labcorp increases minimum hourly wage to $15

Laboratory Corp of America Holdings said on Thursday it has increased the minimum hourly wage for U.S.-based employees to $15, joining several other companies in implementing new measures to retain staff amid a nationwide labor shortage.

Labcorp sees rise in COVID-19 testing as Delta variant spreads (July 29)

(Corrects company name to Labcorp, from LabCorp, in headline and throughout the copy in July 29 story. A previous version of the story had the same error.)

CORRECTED-Labcorp's Q2 profit doubles as non-COVID testing rebounds (July 29)

Laboratory Corporation of America Holdings reported a 102% jump in quarterly profit on Thursday, driven by recovery in its non-COVID-19 testing business and strong demand for its drug development services.

Jana Partners nominates directors at Labcorp, including Crawford

Activist investment firm Jana Partners has nominated directors to the board of life sciences company Laboratory Corp of America Holdings, including Edwin "Mac" Crawford, who has a reputation for turning around struggling companies, sources familiar with the matter said on...

Activist Jana overhauls portfolio, takes stake in Labcorp in fourth quarter - filing

Activist investment firm Jana Partners made big portfolio changes at the end of 2020, buying a stake in life sciences company Laboratory Corp of America Holdings and exiting long-owned stocks including Callaway Golf Co and HD Supply Holdings which was sold to Home Depot.

LabCorp launches test to measure COVID-19 antibodies in clinical trials

LabCorp said on Monday it has launched a test that can measure antibodies a person has produced against the novel coronavirus, to determine the effectiveness of vaccines and drugs against the respiratory illness caused by the virus.

LabCorp says needs to run testing below full capacity for faster results

Laboratory Corporation of America Holdings <LH.N> said on Tuesday it has the capacity to run about 180,000 molecular tests a day and was delivering results in two-three days, but to maintain the speed it will have to perform below full capacity.

LabCorp says need to run testing below full capacity to maintain shorter turnaround time

Laboratory Corporation of America Holdings Chief Executive Officer Adam Schechter said on Tuesday COVID-19 testing should not be run at full capacity to ensure shorter turnaround time for results.

BRIEF-Humana To Offer Labcorp At-Home COVID-19 Test Collection, Collaborate With Walmart And Quest Diagnostics To Offer Drive-Thru Testing For Humana Members

* HUMANA TO OFFER LABCORP AT-HOME COVID-19 TEST COLLECTION AND COLLABORATE WITH WALMART AND QUEST DIAGNOSTICS TO OFFER DRIVE-THRU TESTING FOR HUMANA MEMBERS Source text for Eikon: Further company coverage:

LabCorp launches new neutralizing antibody test for COVID-19

LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus.

LabCorp launches new antibody test for COVID-19

LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus.

BRIEF-LabCorp Launches New Neutralizing Antibody Test

Laboratory Corporation of America Holdings:

LabCorp ties up with software provider to expand virtual clinical trials

Laboratory Corporation of America Holdings (LabCorp) said on Thursday it was partnering with software provider Medable to speed up the adoption of virtual clinical trials, as many participants are dropping out of ongoing studies due to the COVID-19 pandemic.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up